Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Uchiyama Holdings CoTSE:6059 61 EBITDA Margin % is 2.76% as of Mar. 2026, which is 41% below its 10-year median of 4.65. GuruFocus rates TSE:6059 with a GF Score™ of 61/100 and a GF Value™ of 円357.78 (Fairly Valued). The stock has 4 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Uchiyama Holdings Co ranks worse than 65.56% on this metric.
Uchiyama Holdings Co (TSE:6059) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Uchiyama Holdings Co EBITDA Margin % Related Terms
Uchiyama Holdings Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Uchiyama Holdings Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6059 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Uchiyama Holdings Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Uchiyama Holdings Co EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Uchiyama Holdings Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Uchiyama Holdings Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Uchiyama Holdings Co (TSE:6059) has a EBITDA Margin % of 2.76% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Uchiyama Holdings Co and its competitors. This is 41% below median its historical median of 4.65. According to the industry distribution chart, Uchiyama Holdings Co ranks #436 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 65.6%.
Is Uchiyama Holdings Co's EBITDA Margin % too high?
Uchiyama Holdings Co's current EBITDA Margin % of 2.76% is 41% below median its 10-year median of 4.65. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Uchiyama Holdings Co's value of 2.76% is 73% below this industry median. Based on the distribution chart, Uchiyama Holdings Co ranks #436 out of 665 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Uchiyama Holdings Co has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Uchiyama Holdings Co's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Uchiyama Holdings Co ranks #436 out of 665 companies for EBITDA Margin %. This places Uchiyama Holdings Co in the lower half of its industry. The industry median EBITDA Margin % is 10.24. Uchiyama Holdings Co's value of 2.76% is 73% below this benchmark. While the company's 10-year median is 4.65 vs. the industry median of 10.24, Uchiyama Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Uchiyama Holdings Co's current EBITDA Margin % of 2.76% is 73% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Uchiyama Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Uchiyama Holdings Co's current EBITDA Margin % is 2.76%, which is 41% below median its own 10-year median of 4.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Uchiyama Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Uchiyama Holdings Co (TSE:6059) is currently considered Fairly Valued. The stock's GF Value™ is 円357.78, compared to a current price of 円340.00 — trading 5% below its estimated fair value. The current EBITDA Margin % is 2.76%, which is 41% below median its 10-year median of 4.65 and 73% below the Healthcare Providers & Services industry median of 10.24. Uchiyama Holdings Co's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Uchiyama Holdings Co (TSE:6059), the current EBITDA Margin % is 2.76% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Uchiyama Holdings Co (TSE:6059) Overvalued in 2026?
Based on GuruFocus' analysis, Uchiyama Holdings Co stock appears to be undervalued.
The current stock price of 円340.00 is trading 5% below its estimated GF Value™ of 円357.78.
GuruFocus considers Uchiyama Holdings Co to be Fairly Valued.
Key valuation signals for TSE:6059:
EBITDA Margin %: 2.76% (41% below median its 10-year median of 4.65)
GF Value™: 円357.78 vs. price of 円340.00 (5% below fair value)
Industry Position: 73% below the Healthcare Providers & Services median (#436 of 665)
No single metric tells the full story. See the TSE:6059 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Uchiyama Holdings Co Ltd operates nursing care and hotel business through its subsidiary, Sawayaka club and karaoke business, food and drinks business, and real estate business through its subsidiary, Bonner Co. Ltd.
61GF Score
Get the complete analysis for TSE:6059
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6059 has been successfully added to your 
